Outlook Therapeutics, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP
69012T305
SEDOL
N/A
CIK
0001649989
www.outlooktherapeutics.com
LEI:
©
FIGI: BBG00469JRJ5
OTLK
Outlook Therapeutics, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
NAME
Outlook Therapeutics, Inc.
ISIN
US69012T3059
TICKER
OTLK
MIC
XNAS
REUTERS
OTLK.OQ
BLOOMBERG
OTLK US
BUILD THEMEFOLIO SHARE IDEAS DISCUSS
LEVERAGE INVEST
EN 728x90
Financial Intelligence
360° iHub Crowd iFeed ATH Tracker Index Tracker ETF TF Spicy2 X-Billboard
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants
According to the transactions reported via the short sale register, 64.763 shares of Outlook Therapeutics, Inc. are held by short sellers as of 22.11.2024. The graph shows how the positions have changed in the past. A ranking list and further statistics for US stocks can be found here. You can track the activities of short sellers with a focus on European companies here.
Track all markets on TradingView
The charts are provided by TradingView. Millions of investors use the innovative tools and solutions. If you are interested in professional tools, e.g. in the field of technical analysis, you are sure to find what you are looking for here.
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements
The information provided in this area is compiled with care and prepared and processed in complex technical process steps. Quality assurance is an integral part of the methods and procedures used. A plausibility check is carried out to the extent that the source data allows. Before further use, especially in the course of any investment decisions, we recommend consulting at least one second independent source for validation.